• Skip to primary navigation
  • Skip to main content
DB-I Logo

DenseBreast-info, Inc.

Get Smart About Being Dense

HOME/USA

EUROPE

Español

  • Home
  • For Patients
    • Patients Home
    • Dense Breasts: 5 Facts You Should Know
    • Is My Mammogram Enough?
    • Screening Tests After a Mammogram (Table)
    • Let’s Talk About Dense Breasts, Video Series
    • Patient Questions and Answers
    • Patient Resources by Language
    • Print: Patient Fact Sheet
    • Print: Patient Brochure
  • For Providers
    • Providers Home
    • CME/CE: “Dense Breasts, Risk, and Supplemental Screening”
    • Flow Chart: Who Needs More Screening?
    • Health Care Provider FAQs
    • Risk Model Tutorial
    • Table: Mammography Guideline Comparison
    • Table: Dense Breast Screening Guidelines
    • Table: High/Increased-Risk Screening Guidelines
    • DBI Research
    • Patient Resources
  • Screening Technologies
    • Screening Technologies Home
    • For Patients: Screening Tests After a Mammogram (Table)
    • For Providers: Cancer Detection by Screening Method (Table)
    • 2D/3D Mammography
    • Mammography AI Screening Tools, Comparative Tables
    • Breast Ultrasound (Sonogram)
    • Breast MRI
    • Contrast-Enhanced Mammography (CEM)
    • Molecular Breast Imaging
    • DBI Research
  • Inform/Insurance Laws
    • Inform/Insurance Laws Home
    • Inform: Federal FDA Dense Breast Reporting
    • Insurance
      • State Law Insurance Map and Federal HRSA Guidelines
      • State Law Insurance Table
      • Federal Insurance Bill: Find It Early Act
  • Blog & Press
  • About Us
    • About Us Home
    • Our Mission
    • World Dense Breast Day
    • Our Team
    • DBI Research
    • Let’s Talk About Dense Breasts, Video Series
    • Patient Resources
    • Contact Us
    • Please Donate
  • Our Corporate and Health Group Supporters
/ Blog / FDA Updated “Density” Reporting Language
FDA Updated “Density” Reporting Language | Dense Breast Info

FDA Updated “Density” Reporting Language

August 4, 2025 by JoAnn Pushkin

To allow interpreting physicians to provide an overall assessment of breast density that is phrased in the singular, or phrasing that is neither singular nor plural, an FDA alternative standard has been approved, effective immediately, for all facilities subject to MQSA. The singular phrasing is intended to be used in reports to referring providers (not the patient notification) of unilateral mammograms. For more info, visit DBI page FDA National Reporting Standard (see “Report to Referring Providers” section).

DenseBreast‑info, Inc. is an independent, nonprofit organization. DBI is not affiliated with or endorsed by other organizations unless expressly identified. If you have questions about DBI’s programs or partnerships, please contact us.

© Unpublished, DenseBreast-info, Inc. ALL RIGHTS RESERVED | 501(c)(3) Public Charity

  • Online Privacy Policy
  • Online Terms of Use & Disclaimers

This website is for informational purposes only and is not intended to be a substitute for medical advice from a physician or to create a standard of care for health care providers. In addition, information has been provided by independent third parties and may not represent the views of DenseBreast-info.org. Please check with a physician regarding your specific condition, if you have any questions, or need a diagnosis. If you are experiencing an urgent medical condition, call your local emergency services [e.g., 9-1-1 (in the USA) or 1-1-2 (in Europe)].